I agree that I have read this Consent Form and by providing my personal information and clicking “SUBMIT,” I understand and agree that Sanofi U.S., its collaborators, including Regeneron Pharmaceuticals, Inc., its affiliates, and agents (third parties working with, or on behalf of, Sanofi U.S.) (together, “Sanofi”) may use my personal information to: send me periodic or recurring email and/or mail communications that provide information and/or materials related to disease state, products, promotions, services, and research studies; ask my opinion about such information and topics, including performing market research and disease-related surveys; share my personal information with one another to perform these activities; and de-identify it for use in performing research, education, business analytics, marketing studies, and other commercial products. I also understand that Sanofi may combine my personal information with information about me from third parties to better match the communications or materials with my interests. I understand that my consent or enrollment is not required as a condition of purchasing any goods or services, including medications, but I won’t be able to receive communications if I don’t consent.
I understand that I may be contacted by Sanofi in the event I report an adverse event.
I agree that Sanofi may use my personal information, which includes my personal health information, to send me periodic or recurring reminders or other information about my medication.
I understand that if I do not want my information used for the purposes described above, I can close this window and discontinue my registration. I also understand that I can opt-out of continued communications from Sanofi U.S. at any time by visiting , by calling 1-800-633-1610 or by sending a letter to Sanofi US Customer Service, 55 Corporate Drive, P.O. Box 5925 Mailstop 55A-220A, Bridgewater, NJ 08807.
I confirm that I am the authorized user for the email address provided above and I agree to notify Sanofi promptly if the mail or email addresses change in the future.